ESSM Position Statement on Surgical Treatment of Peyronie's Disease

Daniar Osmonov, MD, PhD, FECSM; Ahmed Ragheb, MD, PhD, FECSM; Sam Ward, MD, FEBU, FECSM; Gideon Blecher, MD, FECSM; Marco Falcone, MD, PhD, FECSM; Armin Soave, MD, PhD, FEBU, FECSM, EAA; Roland Dahlem, MD, PhD; Koenraad van Renterghem, MD, PhD; Nim Christopher, MD, PhD; Georgios Hatzichristodoulou, MD, PhD, FEBU, FECSM; Mirko Preto, MD, PhD; Giulio Garaffa, MD, PhD, FECSM, FRCS (Eng); Maarten Albersen, MD, PhD, FEBU, FECSM; Carlo Bettocchi, MD, PhD, FECSM; Giovanni Corona, MD, PhD, FECSM; Yacov Reisman, MD, PhD, FECSM

Sexual Medicine (Feb 2022)

ESSM Position Statement on Surgical Treatment of Peyronie's Disease

Daniar Osmonov, MD, PhD, FECSM,
Ahmed Ragheb, MD, PhD, FECSM,
Sam Ward, MD, FEBU, FECSM,
Gideon Blecher, MD, FECSM,
Marco Falcone, MD, PhD, FECSM,
Armin Soave, MD, PhD, FEBU, FECSM, EAA,
Roland Dahlem, MD, PhD,
Koenraad van Renterghem, MD, PhD,
Nim Christopher, MD, PhD,
Georgios Hatzichristodoulou, MD, PhD, FEBU, FECSM,
Mirko Preto, MD, PhD,
Giulio Garaffa, MD, PhD, FECSM, FRCS (Eng),
Maarten Albersen, MD, PhD, FEBU, FECSM,
Carlo Bettocchi, MD, PhD, FECSM,
Giovanni Corona, MD, PhD, FECSM,
Yacov Reisman, MD, PhD, FECSM

Affiliations

Daniar Osmonov, MD, PhD, FECSM: Department of Urology and Pediatric Urology, University Hospital Schleswig-Holstein, Kiel, Germany; Corresponding Author: Daniar Osmonov, MD, PhD, FECSM, Associate Professor of Urology, Head of Andrology Unit in the Department of Urology, University Medical Center Schleswig Holstein, Campus Kiel, Christian Albrechts University of Kiel, Arnold Heller Str. 5, Kiel 24105, Germany. Tel: 043159724800
Ahmed Ragheb, MD, PhD, FECSM: Department of Urology, Beni-Suef University, Bedaya Fertility & IVF Hospitals, Kairo, Egypt
Sam Ward, MD, FEBU, FECSM: Department of Urology, Clinique Saint Jean, Brussels; Medicis Medical Center, Woluwe, Belgium
Gideon Blecher, MD, FECSM: Department of Surgery, Monash University, Melbourne; Department of Urology, The Alfred Hospital, Melbourne, Australia
Marco Falcone, MD, PhD, FECSM: Department of Urology, University of Turin – Cittàdella Salute e dellaScienza, Turin, Italy
Armin Soave, MD, PhD, FEBU, FECSM, EAA: Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Roland Dahlem, MD, PhD: Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Koenraad van Renterghem, MD, PhD: Department of Urology, Jessa Ziekenhuis Campus Salvator, Hasselt, Belgium
Nim Christopher, MD, PhD: The Institute of Urology, University College London Hospitals, London, UK
Georgios Hatzichristodoulou, MD, PhD, FEBU, FECSM: Department of Urology, Hospital Nürnberg, Nürnberg, Germany
Mirko Preto, MD, PhD: Department of Urology, University of Turin – Cittàdella Salute e dellaScienza, Turin, Italy
Giulio Garaffa, MD, PhD, FECSM, FRCS (Eng): The Institute of Urology, University College London Hospitals, London, UK
Maarten Albersen, MD, PhD, FEBU, FECSM: Department of Urology, UZ Leuven Gasthuisberg Campus, Leuven, Belgium
Carlo Bettocchi, MD, PhD, FECSM: Department of Urology, University Bari, Bari, Italy
Giovanni Corona, MD, PhD, FECSM: Endocrinology Unit, Medical Department, AziendaUsl Bologna Maggiore-Bellaria Hospital, Bologna, Italy
Yacov Reisman, MD, PhD, FECSM: Flare-Health, Amstelveen, The Netherlands

Journal volume & issue: Vol. 10, no. 1
p. 100459

Abstract

Read online

Introduction: Patients with Peyronie's disease may experience significat distress. The choice of treatment depends on a variety of factors, including the stage of the disease, the presence of pain, severity and direction of the curvature, penile length and the quality of erectile function. Aim: To review the evidence associated with surgical treatment of Peyronie`s Disease and provide clinical recommendations on behalf of the European Society for Sexual Medicine. 131 peer-reviewed studies and systematic reviews, which were published from 2009 to 2019 in the English language, were included. Methods: MEDLINE, Google Scholar and EMBASE were searched for randomized clinical trials, meta-analyses, open-label prospective and retrospective studies. Main Outcome Measure: The panel provided statements on clinically relevant questions including patient involvement in the decision process, indications for surgery, choice of the approach, and the management of patient expectations. A comparison of the different grafts used in patients who have undergone plaque incision/excision and grafting in order to identify an ideal graft, has been carried out. The prevalence of postoperative complications has been summarized. Levels of evidence were provided according to the Oxford 2011 criteria and Oxford Centre for Evidence-Based Medicine recommendations. Results: In order to allow shared decision making, a patient preoperative counselling regarding the pros and cons of each intervention is recommended. In particular, adverse effects of surgical treatments should be discussed to set realistic understanding and expectations of surgical outcomes and ultimately improve postoperative satisfaction rates. Surgical treatment should be only offered in the chronic phase of the condition, when the deformity and/or degree of erectile dysfunction, prevent patients from engaging in satisfying sexual interaction, or if the deformity is the cause of severe bother. Conclusions: Current European Society for Sexual Medicine recommendations cover several aspects of Peyronie's disease treatment. These recommendations aim both to ensure patients and partners have accurate and realistic expectations of their treatment options, as well as to formulate algorithms to guide clinician management pathways.Osmonov D, Ragheb A, Ward S et al, ESSM Position Statement on Surgical Treatment of Peyronie's Disease. Sex Med 2022;10:100459.

Published in Sexual Medicine

ISSN: 2050-1161 (Online)
Publisher: Oxford University Press
Country of publisher: United Kingdom
LCC subjects: Medicine
Website: https://academic.oup.com/smoa

About the journal

Abstract

Keywords